The Patent Finder

PathogenDx, Inc.

15 patents currently held · Updated Nov 14, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Jun 2036
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 18, 2027
    The maintenance fee for Combinatorial Microarray Assay for Clade Variant Detection (US 11,702,709) comes due Jan 18, 2027. Unpaid by Jul 19, 2027, it lapses early.
  • 1 fee due Apr 10, 2027
    The maintenance fee for Microarray based multiplex pathogen analysis and uses thereof (US 11,781,133) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
  • 3 fees due Jun 10 to 26, 2027 · next Jun 10
  • 1 fee due Oct 7, 2027
    The maintenance fee for Microarray based multiplex pathogen analysis and uses thereof (US 10,612,075) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.
  • 1 fee due Nov 5, 2027
    The maintenance fee for Microarray based multiplex pathogen analysis and uses thereof (US 10,640,835) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US D922,605Medical waste treatment device
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,501,814Microarray based multiplex pathogen analysis and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,513,745Microarray based multiplex pathogen analysis and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,640,835Microarray based multiplex pathogen analysis and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,767,235Microarray based multiplex pathogen analysis and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,421,224Microarray based multiplex pathogen analysis and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,512,307Microarray based multiplex pathogen analysis and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,781,133Microarray based multiplex pathogen analysis and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,612,075Microarray based multiplex pathogen analysis and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,851,705Microarray based multiplex pathogen analysis for plants, agriculture, food, and water
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited